Accepted for/Published in: JMIR Formative Research
Date Submitted: Oct 19, 2022
Date Accepted: Dec 27, 2022
Date Submitted to PubMed: Jan 4, 2023
Utilization of and satisfaction with a mobile health education during the COVID-19 pandemic in Thailand: Cross-sectional study
ABSTRACT
Background:
RamaCovid is a mobile health application that provides the Thai population with information about COVID-19 and self-risk assessment. RamaCovid has a chatbot system that provides automatic conversations (available 24 hours per day) and a live chat function that allows users to directly communicate with health professionals (available 4 hours per day in the evening).
Objective:
This study investigated users’ utilization of and satisfaction with the RamaCovid application.
Methods:
Overall, 400 people were included and were recruited via RamaCovid by broadcasting an infographic about the study. Questionnaires collected demographic data, users’ experiences of RamaCovid, and the utilization of and satisfaction with the application. The questions were answered via a 5-point Likert scale.
Results:
The users had high utilization and satisfaction with the application. They used the information to take care of themselves and their family, and they gained information about their COVID-19 risk. The users were satisfied with the application because the information was easy to understand, trustworthy, and up to date.
Conclusions:
RamaCovid provides an example of the successful implementation of an educational mobile health application. It facilitates the communication of trustworthy and up-to-date information and has enhanced people’s ability to take care of themselves and their family during the COVID-19 pandemic.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.